Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans to acquire the company for $77 per share.
Stocks · News reference
Bio Green Med Solution Q2 EPS $(0.08) Up From $(0.93) YoY, Sales $336.000K
Bio Green Med Solution (NASDAQ:BGMS) reported quarterly losses of $(0.08) per share. This is a 91.4 percent increase over losses of $(0.93) per share from the same period last year. The company reported $336.000
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
The M&A Class Action Firm Encourages $hareholders to Contact Monteverde Concerning The Merger—PFLC, NUVL, CCRN, and BGMS
Monteverde & Associates PC is investigating four merger and acquisition transactions on behalf of shareholders. Pacific Financial Corporation is merging with Banner Corporation (0.2633 shares per share), Nuvalent Inc. is being acquired by GSK plc ($124.00 per share), Cross Country Healthcare is being sold to KL Criss Cross Intermediate LLC ($13.25 per share), and Bio Green Med Solution is merging with Future NRG Sdn. Bhd. Shareholders are encouraged to contact the firm regarding potential concerns with these transactions.